SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | Vir Biotechnology, Inc. | 12,297,139 | 9.1% | EDGAR |
SC 13G/A | 2024-02-13 | SB INVESTMENT ADVISERS (UK) LTD | Vir Biotechnology, Inc. | 16,684,041 | 12.4% | EDGAR |
SC 13G | 2024-01-24 | STATE STREET CORP | Vir Biotechnology, Inc. | - | 5.1% | EDGAR |
SC 13G/A | 2024-01-23 | BlackRock Inc. | Vir Biotechnology, Inc. | 16,864,579 | 12.5% | EDGAR |
SC 13G/A | 2023-02-14 | SOFTBANK VISION FUND (AIV M1) L.P. | Vir Biotechnology, Inc. | 20,259,535 | 15.2% | EDGAR |
SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | Vir Biotechnology, Inc. | 10,094,501 | 7.6% | EDGAR |
SC 13G/A | 2023-01-24 | BlackRock Inc. | Vir Biotechnology, Inc. | 14,136,628 | 10.6% | EDGAR |
SC 13D/A | 2022-09-13 | ARCH Venture Fund IX, L.P. | Vir Biotechnology, Inc. | 12,916,663 | 9.7% | EDGAR |
SC 13G | 2022-09-08 | BlackRock Inc. | Vir Biotechnology, Inc. | 13,384,194 | 10.1% | EDGAR |
SC 13D/A | 2022-05-10 | ARCH Venture Fund IX, L.P. | Vir Biotechnology, Inc. | 18,916,663 | 14.5% | EDGAR |
SC 13G/A | 2022-02-14 | SCANGOS GEORGE A | Vir Biotechnology, Inc. | 6,266,581 | 4.8% | EDGAR |
SC 13G/A | 2022-02-11 | Capital International Investors | Vir Biotechnology, Inc. | 5,634,019 | 4.3% | EDGAR |
SC 13G/A | 2022-02-10 | GLAXOSMITHKLINE PLC | Vir Biotechnology, Inc. | 8,550,954 | 6.5% | EDGAR |
SC 13G | 2022-02-10 | VANGUARD GROUP INC | Vir Biotechnology, Inc. | 7,330,131 | 5.6% | EDGAR |
SC 13D/A | 2022-01-10 | ARCH Venture Fund IX, L.P. | Vir Biotechnology, Inc. | 18,916,663 | 14.5% | EDGAR |
SC 13D/A | 2021-07-12 | ARCH Venture Fund IX, L.P. | Vir Biotechnology, Inc. | 21,666,663 | 16.7% | EDGAR |
SC 13D/A | 2021-04-14 | ARCH Venture Fund IX, L.P. | Vir Biotechnology, Inc. | 26,666,663 | 20.8% | EDGAR |
SC 13G/A | 2021-02-16 | Alaska Permanent Fund Corp | Vir Biotechnology, Inc. | 3,893,040 | 3.1% | EDGAR |
SC 13G | 2021-02-16 | Capital International Investors | Vir Biotechnology, Inc. | 11,440,571 | 9.0% | EDGAR |
SC 13G | 2021-02-16 | Capital International Investors | Vir Biotechnology, Inc. | 11,440,571 | 9.0% | EDGAR |